Documented concern based on cited evidence — not a personalized safety check, not medical advice, and not a decision to combine or avoid. That decision belongs with your prescriber.
Low-grade concern — timing, disclosure, or lab context
Low-grade documented concern. Timing, disclosure, or a lab context decides whether it matters for you.
Mechanism and evidence
Antiplatelet effect of high-dose omega-3 adds to anticoagulation; the direct warfarin cohort found no significant signal, and no comparable DOAC-specific cohort exists.
Evidence tier: label-mechanistic
The tier names the strongest cited study design. Some anchors studied the supplement on its own, or a related drug in the same class — in those pairs the grade rests on that evidence plus established pharmacology, as agreed with our medical reviewer.
What to discuss with your prescriber
- Mention high-dose fish oil to your prescriber.
- Keep intake stable.
← All reviewed pairs for DOACs (apixaban, rivaroxaban, dabigatran, edoxaban)